Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Stock Analysis

Why Ora Banda Mining (ASX:OBM) Has Started Waihi Underground Development and Upsized Its Credit Facility to A$300 Million

Ora Banda Mining (ASX:OBM) has released its September 2026 quarterly report, saying development of the Waihi Underground has begun ahead of schedule and construction of its new 3.0 Mtpa processing plant is under way on schedule and within budget. The company produced 33,305 oz …

Sonal Goyal | 23 October 2026

Why Orbital (ASX:OEC) Has Signed Its First Power by the Hour Engine Contract for US Unmanned Aircraft

Orbital Corporation (ASX:OEC) has signed its first Power by the Hour (PBH) contract, with American Aerospace Technologies Inc. (AATI), a United States developer and operator of long-endurance unmanned aircraft. The company says the agreement is worth US$2.6 million (A$3.7 million) in contractRevenueand runs to …

Sonal Goyal | 23 October 2026

Why Orpheus Uranium (ASX:ORP) Has Begun Maiden Drilling at Its Frome Uranium Project in South Australia

Orpheus Uranium (ASX:ORP) has reported that its maiden drilling programme at the Erudina palaeochannel within its Frome project in South Australia began after a rig arrived on 29 July 2026. The September 2026 quarterly activities report also covers two acquisitions that have not yet …

Sonal Goyal | 23 October 2026

Why Paradigm Biopharmaceuticals (ASX:PAR) Administrators Are Seeking a Court Extension and Have Redeemed Further Convertible Notes

The voluntary administrators of Paradigm Biopharmaceuticals Limited (ASX:PAR) (Administrators Appointed) have applied to the Supreme Court of Western Australia to extend the convening period for the second meeting of creditors by up to three months. Separately, the company has paid US$348,900.38 to redeem a …

Sonal Goyal | 23 October 2026

Why Proteomics International (ASX:PIQ) Is Taking Its PromarkerD and PromarkerEso Diagnostic Tests National Through Healius

Proteomics International Laboratories (ASX:PIQ) has announced the national rollout of two of its Promarker diagnostic tests, PromarkerD and PromarkerEso, through its exclusive Australian pathology distribution partner, Healius Limited (ASX:HLS). The company said the rollout and supporting systems are scheduled to go live on Monday …

Sonal Goyal | 23 October 2026

Why Patagonia Lithium (ASX:PL3) Reported Its Jujuy Demonstration Plant Application Gazetted and a Five-Week Delay to Its Resource Update

Patagonia Lithium (ASX:PL3) has given a progress update on its Argentine brine projects in which the central development is regulatory: its application to build a 1,000-tonne lithium carbonate demonstration plant in Jujuy Province was gazetted in Provincial Official Gazette No. 121 on 9 October …

Sonal Goyal | 23 October 2026

Why QMines (ASX:QML) Has Completed the Sale of Its QDrilling Subsidiary to Gas Field Services for $1.4 Million in Deferred Payments

QMines Limited (ASX:QML) has completed the sale of its wholly owned drilling subsidiary, QDrilling Pty Ltd, to Gas Field Services Pty Ltd for total consideration of $1.4 million. The company said the buyer takes 100 per cent of QDrilling's issued capital. The price is …

Sonal Goyal | 23 October 2026

Why Reef Casino Trust (ASX:RCT) Has Lodged Its Target's Statement on Iris Cairns Property's $4.67 Cash Takeover Offer

Reef Casino Trust (ASX:RCT) has lodged its Target's Statement responding to an unconditional off-market takeover bid from Iris Cairns Property Pty Ltd, asTrusteefor the Iris Cairns Property Trust, part of the Iris Group trading as Iris Capital. The trust's three-member Independent Board Committee said …

Sonal Goyal | 23 October 2026

Why RAM Essential Services Property Fund (ASX:REP) Has Settled the $218.6 Million Sale of Five Retail Assets

RAM Essential Services Property Fund (ASX:REP) has announced that the sale of five retail assets, valued at $218.6 million, settled on 22 October 2026. The announcement, issued by the board of the responsible entity, RAM Property Funds Management Limited, follows an earlier release on …

Sonal Goyal | 23 October 2026

Why Argent BioPharma (ASX:RGT) Reported $11,000 of Cash at 30 September 2026 and A$3.6 Million Drawn on Its Convertible Note Facility

Argent BioPharma (ASX:RGT) has released its Appendix 4C and quarterly activities report for the three months to 30 September 2026. The reported figures are a net operating cash outflow of A$734,000 and closing cash of A$11,000, with A$600,000 drawn from convertibleDebtsecurities. The company also …

Sonal Goyal | 23 October 2026
Support

Hi! How can we help you today?

Loading…